Merck Life Science arm, Department of Atomic Energy collaborate for heavy water supply
AK Mohanty, secretary of DAE and chairman of the Atomic Energy Commission, said local production of DLCs by private parties will boost exports from India.
Advertisement
Mumbai: The Department of Atomic Energy on Thursday tied up with pharma company Merck Life Science to supply heavy water for five years.
The agreement between Heavy DAE's Heavy Water Board and Merck's sister concern Sigma Aldrich Chemicals will enable the production of deuterium labelled compounds (DLCs) and allied value-added products, as per an official statement.
AK Mohanty, secretary of DAE and chairman of the Atomic Energy Commission, said local production of DLCs by private parties will boost exports from India.
"Investment in India for manufacturing of deuterated products will benefit the country with respect to the growth of local chemicals and pharmaceutical sectors, thus increasing the supply of high-value products," he said.
The agreement was signed between HWB's director for operation VVSA Prasad and Merck's managing director Sreenath Narayanaiah at DAE's office in south Mumbai in the presence of Mohanty, DAE's additional secretary A R Sule, HWB chairman and chief executive J Srivastava, the statement said.
Read also: Merck appoints Helene von Roeder as new CFO
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.